Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

To determine the role of surfactant protein-A(SP-A) in antiviral host defense, mice lacking SP-A (SP-A-/-) were produced by targeted gene inactivation. SP-A-/- and control mice (SP-A+/+) were infected with respiratory syncytial virus (RSV) by intratracheal instillation. Pulmonary infiltration after infection was more severe in SP-A-/- than in SP-A+/+ mice and was associated with increased RSV plaque-forming units in lung homogenates. Pulmonary infiltration with polymorphonuclear leukocytes was greater in the SP-A-/- mice. Levels of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-6 were enhanced in lungs of SP-A-/- mice. After RSV infection, superoxide and hydrogen peroxide generation was deficient in macrophages from SP-A-/- mice, demonstrating a critical role of SP-A in oxidant production associated with RSV infection. Coadministration of RSV with exogenous SP-A reduced viral titers and inflammatory cells in the lung of SP-A-/- mice. These findings demonstrate that SP-A plays an important host defense role against RSV in vivo.

[1]  W. Watford,et al.  Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. , 1999, American journal of respiratory cell and molecular biology.

[2]  J. Whitsett,et al.  Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. , 1998, American journal of respiratory cell and molecular biology.

[3]  M. Griese,et al.  Pulmonary surfactant in cystic fibrosis. , 1997, The European respiratory journal.

[4]  W. Martin,et al.  Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. , 1997, American journal of respiratory cell and molecular biology.

[5]  J. Whitsett,et al.  Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. , 1997, Journal of immunology.

[6]  B. Benaissa-Trouw,et al.  Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages , 1997, European journal of immunology.

[7]  B. Stripp,et al.  Altered surfactant function and structure in SP-A gene targeted mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Dargaville,et al.  Surfactant abnormalities in infants with severe viral bronchiolitis. , 1996, Archives of disease in childhood.

[9]  J. Wright,et al.  Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages. , 1996, The American journal of physiology.

[10]  M. Pollack,et al.  Surfactant content in children with inflammatory lung disease. , 1996, Critical care medicine.

[11]  K. Schwarz,et al.  Oxidative stress during viral infection: a review. , 1996, Free radical biology & medicine.

[12]  J. Panuska,et al.  Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta. , 1995, American journal of respiratory and critical care medicine.

[13]  J. Whitsett,et al.  SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains. , 1995, American journal of respiratory and critical care medicine.

[14]  M. Harmsen,et al.  Interactions of surfactant protein A with influenza A viruses: binding and neutralization. , 1995, The Journal of infectious diseases.

[15]  S. Seidner,et al.  SP-A Deficiency in Primate Model of Bronchopulmonary Dysplasia with Infertion , 1995 .

[16]  S. Kremlev,et al.  Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. , 1994, The American journal of physiology.

[17]  T. Schaberg,et al.  Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. , 1994, The American journal of physiology.

[18]  M. Daha,et al.  Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. , 1994, The American journal of physiology.

[19]  J. Coonrod,et al.  Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. , 1994, American journal of respiratory cell and molecular biology.

[20]  J. Wright,et al.  Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. , 1993, The American journal of physiology.

[21]  R. Ezekowitz,et al.  Collectins: pattern recognition molecules involved in first line host defense. , 1993, Current opinion in immunology.

[22]  Coonrod Jd,et al.  Comparison of the Opsonic Activity of Human Surfactant Protein A for Staphylococcus aureus and Streptococcus pneumoniae with Rabbit and Human Macrophages , 1993 .

[23]  J. Coonrod,et al.  Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. , 1993, The Journal of infectious diseases.

[24]  J. Verhoef,et al.  Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. , 1992, The Journal of biological chemistry.

[25]  E. Crouch,et al.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. , 1992, The Journal of clinical investigation.

[26]  J. Wright,et al.  Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. , 1992, The American journal of physiology.

[27]  H. Plattner,et al.  Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. , 1992, European journal of cell biology.

[28]  S. Becker,et al.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. , 1991, Journal of immunology.

[29]  J. Verhoef,et al.  Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. , 1991, The American journal of physiology.

[30]  K. Maier,et al.  Effect of canine surfactant protein (SP‐A) on the respiratory burst of phagocytic cells , 1990, FEBS letters.

[31]  S. Thiel,et al.  Human leukocyte C1q receptor binds other soluble proteins with collagen domains , 1990, The Journal of experimental medicine.

[32]  R. Dessau,et al.  In Vivo and In Vitro Antibacterial Activity of Conglutinin, a Mammalian Plasma Lectin , 1990, Scandinavian journal of immunology.

[33]  J. Verhoef,et al.  Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.

[34]  J. Whitsett,et al.  Surfactant protein‐A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high‐frequency oscillatory ventilation , 1990, Pediatric pulmonology.

[35]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[36]  N. Roberts,et al.  Interleukin‐1 Inhibitor Production by Human Mononuclear Leukocytes and Leukocyte Subpopulations Exposed to Respiratory Syncytial Virus: Analysis and Comparison With the Response to Influenza Virus , 1989, Journal of leukocyte biology.

[37]  E. Wald,et al.  Duration of hospitalization in previously well infants with respiratory syncytial virus infection , 1989, The Pediatric infectious disease journal.

[38]  J. Wright,et al.  Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Kenneth Reid,et al.  Structures and functions associated with the group of mammalian lectins containing collagen‐like sequences , 1989, FEBS letters.

[40]  J. Groopman,et al.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus , 1989, The Journal of experimental medicine.

[41]  M. Perkins,et al.  Primary respiratory syncytial virus infection in mice , 1988, Journal of medical virology.

[42]  W. Busse,et al.  Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. , 1988, The Journal of allergy and clinical immunology.

[43]  K. Drickamer,et al.  The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. , 1987, The Journal of biological chemistry.

[44]  H. Faden,et al.  Interaction of polymorphonuclear leukocytes and viruses in humans: adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells , 1984, Journal of virology.

[45]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. , 1973, American journal of epidemiology.